Top compounds associated with response to HINT1


Feature Type Standardized
Nominal ANOVA
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.064 0.08
mRNA Bryostatin 1 FIMM pan-cancer AAC -0.24 0.08
mRNA Zebularine CTRPv2 pan-cancer AAC -0.061 0.08
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.08
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC -0.095 0.09
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.053 0.09
mRNA Crizotinib gCSI pan-cancer AAC 0.092 0.09
mRNA JW-74 CTRPv2 pan-cancer AAC -0.077 0.09
mRNA apicidin CTRPv2 pan-cancer AAC -0.053 0.09
Download CSV